Celldex Therapeutics, Inc.

Historical 13F Holders

Symbol
CLDX
CUSIP
15117B202
All holders as of
Q3 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 15117B202 since 12/18/2024, largest first.

Filer % of Class Filed
Wellington Management Group LLP 13G/A
13.9% 11/16/2026
Event 9/30/2026
FMR LLC 13G/A
10.7% 10/7/2026
Event 9/30/2026
BlackRock, Inc. 13G/A 7.3% 4/17/2025
Event 3/31/2025
Kynam Capital Management, LP 13G/A
6.8% 8/14/2026
Event 6/30/2026
Price T Rowe Associates Inc /MD/ 13G 6.0% 8/14/2026
Event 6/30/2026
Vanguard Capital Management LLC 13G 5.2% 4/29/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (6)
Commodore Capital LP 13G/A
4.6% 11/14/2025
Event 9/30/2025
State Street Corp 13G 4.2% 5/12/2026
Event 3/31/2026
Point72 Asset Management, L.P. 13G/A
2.6% 3/10/2026
Event 12/31/2025
Eventide Asset Management, LLC 13G/A
2.0% 8/14/2025
Event 6/30/2025
Bellevue Group AG 13G/A
1.5% 5/15/2026
Event 3/31/2026
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 254 89.6 M $2.90B
2026 Q2 260 85.0 M $3.16B
2026 Q1 233 72.9 M $2.31B
2025 Q4 191 73.6 M $2.00B
2025 Q3 191 70.7 M $1.83B
2025 Q2 185 72.7 M $1.48B
2025 Q1 175 73.6 M $1.34B
2024 Q4 183 73.7 M $1.86B
2024 Q3 185 71.8 M $2.44B
2024 Q2 186 69.6 M $2.58B
2024 Q1 202 69.3 M $2.91B
2023 Q4 168 61.0 M $2.42B
2023 Q3 149 50.6 M $1.39B
2023 Q2 153 50.2 M $1.70B
2023 Q1 165 49.5 M $1.78B
2022 Q4 170 48.7 M $2.17B
2022 Q3 163 49.3 M $1.39B
2022 Q2 167 48.2 M $1.30B
2022 Q1 173 49.6 M $1.69B
2021 Q4 184 46.3 M $1.79B
2021 Q3 166 43.3 M $2.34B
2021 Q2 136 35.6 M $1.19B
2021 Q1 119 34.5 M $710M
2020 Q4 133 36.8 M $645M
2020 Q3 97 32.2 M $477M
2020 Q2 78 27.8 M $361M
2020 Q1 47 3.96 M $6.59M
2019 Q4 49 3.91 M $8.71M
2019 Q3 58 3.71 M $7.90M
2019 Q2 54 3.47 M $9.29M
2019 Q1 56 2.60 M $12.8M
2018 Q4 1 100 k $20.0k